80
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Clinical Management of Asthma by Respiratory Specialists versus General Practitioners: Questionnaire Survey Results Over 6 Years

, ORCID Icon, , , ORCID Icon, ORCID Icon, , & show all
Pages 1003-1011 | Published online: 23 Mar 2021

References

  • Ernst P, Spitzer WO, Suissa S, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA. 1992;268(24):3462–3464. doi:10.1001/jama.1992.03490240070039
  • Tada M, Kuraki T, Taooka Y, et al. Comparison of clinical management of young and elderly asthmatics by respiratory specialists and general practitioner. J Asthma. 2015;52(2):162–169. doi:10.3109/02770903.2014.928311
  • Nathan RA, Sorkness CA, Kosinski M, et al. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.008
  • Morishima T, Otsubo T, Gotou E, et al. Physician adherence to asthma treatment guidelines in Japan: focus on inhaled corticosteroids. J Eval Clin Pract. 2013;19(2):223–229. doi:10.1111/j.1365-2753.2011.01708.x
  • Iwanaga T, Kumur M, Goren A, et al. Cross sectional patient-reported survey on asthma control and associated burdens in Japanese patients with asthma in 2013. Ther Res. 2015;36:235–246.
  • Nelson HS, Chapman KR, Pyke SD, et al. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol. 2003;112(1):29–36. doi:10.1067/mai.2003.1558
  • Seki R, Nagatomo Y, Yamaguchi T, et al. Ten-year questionnaire survey on adult asthma patients in Miyazaki Prefecture, Japan. Arerugi. 2014;63(6):794–804.
  • Tamaoki J, Kondo M, Sakai N, et al. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi Idai Asthma Research Group. Am J Respir Crit Care Med. 1997;155(4):1235–1240. doi:10.1164/ajrccm.155.4.9105060
  • Tohda Y, Fujimura M, Taniguchi H, et al. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Clin Exp Allergy. 2002;32(8):1180–1186. doi:10.1046/j.1365-2745.2002.01440.x
  • Price D, Musgrave SD, Shepstone L, et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med. 2011;364(18):1695–1707. doi:10.1056/NEJMoa1010846
  • Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med. 2010;363(18):1715–1726. doi:10.1056/NEJMoa1008770
  • Kerstjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012;367(13):1198–1207. doi:10.1056/NEJMoa1208606
  • Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–938. doi:10.1016/j.rmed.2011.01.005
  • Tamura G, Ohta K. Adherence to treatment by patients with asthma and COPD:comparison between inhaled drugs and transdermal patch. Respir Med. 2007;101(9):1895–1902. doi:10.1016/j.rmed.2007.05.001
  • Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288–1293. doi:10.1016/j.jaci.2004.09.028
  • Hira D, Komase Y, Koshiyama S, et al. Problems of elderly patients on inhalation therapy:difference in problem recognition between patients and medical professionals. Allergol Int. 2016;65(4):444–449. doi:10.1016/j.alit.2016.04.002
  • Hoskins G, McCowan C, Neville RG, et al. Risk factors and costs associated with an asthma attack. Thorax. 2000;55(1):19–24. doi:10.1136/thorax.55.1.19
  • GSK. Asthma Control Test. Available from: https://www.asthmacontroltest.com/en-au/welcome/. Accessed March 12, 2021.